Clinical Trial Update: Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update for intratumoral gemcitabine, paclitaxel, and carboplatin with intravenous nivolumab in locally recurrent head and neck squamous cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Paclitaxel (Taxol) (paclitaxel)
• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Squamous Cell Carcinoma of the Head and Neck, Paclitaxel | Phase 2 | Status: NOT_YET_RECRUITING